ArticleCirculation. Heart failure2026

Efficacy and Safety of Aficamten in Children and Adolescents With Obstructive Hypertrophic Cardiomyopathy: Study Design and Rationale of CEDAR-HCM.

Juan Pablo Kaski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.